{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:59:19Z","timestamp":1792083559647,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.cca.2026.121245","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:54:49Z","timestamp":1784822089000},"page":"121245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pheochromocytoma as a manifestation of Neurofibromatosis type 1: Clinical presentation, diagnosis, and genetic analysis"],"prefix":"10.1016","volume":"593","author":[{"given":"Neus","family":"Baena-D\u00edez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Cano-Corres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Leon","family":"Mengibar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael Capel","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121245_bb0005","series-title":"Neurofibromatosis 1 [Internet]. GeneReviews\u00ae - NCBI Bookshelf","author":"Friedman","year":"2025"},{"key":"10.1016\/j.cca.2026.121245_bb0010","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.cca.2026.121245_bb0015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13023-023-02911-2","article-title":"Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis","volume":"18","author":"Lee","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"issue":"10","key":"10.1016\/j.cca.2026.121245_bb0020","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/pbc.25556","article-title":"Rhabdomyosarcomas in children with neurofibromatosis type I: a national historical cohort","volume":"62","author":"Crucis","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.cca.2026.121245_bb0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cen.13163","article-title":"Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1","volume":"86","author":"Gruber","year":"2017","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"6","key":"10.1016\/j.cca.2026.121245_bb0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00535-015-1132-6","article-title":"Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I","volume":"51","author":"Nishida","year":"2016","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cca.2026.121245_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaad.2014.01.913","article-title":"Glomus tumors in individuals with neurofibromatosis type 1","volume":"71","author":"Kumar","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cca.2026.121245_bb0040","first-page":"95","article-title":"Clinical presentation and outcomes of phaeochromocytomas\/paragangliomas in neurofibromatosis type 1","volume":"15","author":"Al-Sharefi","year":"2019","journal-title":"Eur Endocrinol."},{"key":"10.1016\/j.cca.2026.121245_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/710514","article-title":"Adrenal tumors with unexpected outcome: a review of the literature","volume":"2015","author":"Kerkhofs","year":"2015","journal-title":"Int. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.cca.2026.121245_bb0050","article-title":"An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma","volume":"34","author":"Burnichon","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.cca.2026.121245_bb0055","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.3390\/biomedicines12102385","article-title":"Pheochromocytoma\u2013paraganglioma syndrome: a multiform disease with different genotype and phenotype features","volume":"12","author":"Giacch\u00e9","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2026.121245_bb0060","doi-asserted-by":"crossref","first-page":"bvad083","DOI":"10.1210\/jendso\/bvad083","article-title":"Prevalence of endocrine manifestations and GIST in 108 systematically screened patients with Neurofibromatosis type 1","volume":"7","author":"Dupuis","year":"2023","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.cca.2026.121245_bb0065","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1245\/s10434-013-2942-5","article-title":"Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing","volume":"20","author":"Fishbein","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.cca.2026.121245_bb0070","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1530\/ERC-11-0170","article-title":"Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas","volume":"18","author":"Welander","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.cca.2026.121245_bb0075","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","article-title":"Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention","volume":"3","author":"Bausch","year":"2017","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.cca.2026.121245_bb0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","article-title":"The north American neuroendocrine tumor society consensus guidelines for surveillance and management of metastatic and\/or unresectable pheochromocytoma and paraganglioma","volume":"50","author":"Fishbein","year":"2021","journal-title":"Pancreas"},{"issue":"5","key":"10.1016\/j.cca.2026.121245_bb0085","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00403-010-1090-z","article-title":"Neurofibromatosis type 1 and pheochromocytoma: prevalence, clinical and cardiovascular aspects","volume":"303","author":"Zinnamosca","year":"2011","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.cca.2026.121245_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/cen.15248","article-title":"Genetic testing referral rates for pheochromocytoma and paraganglioma in an academic tertiary centre","author":"Ruhle","year":"2025","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"2","key":"10.1016\/j.cca.2026.121245_bb0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3892\/etm.2024.12784","article-title":"Clinical exome next-generation sequencing panel for hereditary pheochromocytoma and paraganglioma diagnosis","volume":"29","author":"Melli","year":"2025","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cca.2026.121245_bb0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/bjc.2012.535","article-title":"Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis","volume":"108","author":"Seminog","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cca.2026.121245_bb0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr. Rev."},{"issue":"12","key":"10.1016\/j.cca.2026.121245_bb0110","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0248-8663(00)00268-X","article-title":"Progr\u00e8s r\u00e9cents dans le diagnostic, l\u2019\u00e9valuation pronostique et le traitement des ph\u00e9ochromocytomes","volume":"21","author":"Plouin","year":"2000","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.cca.2026.121245_bb0115","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126004274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:28:27Z","timestamp":1792081707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126004274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":23,"alternative-id":["S0009898126004274"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121245","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pheochromocytoma as a manifestation of Neurofibromatosis type 1: Clinical presentation, diagnosis, and genetic analysis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121245"}}